Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Manage Cloud Costs, Increase Cloud Security, and Improve Operational Efficiencies with Upland Cimpl Cloud: https://mms.businesswire.com/media/20191107006065/en/707094/5/Upland-Blue-cmyk.jpg
Manage Cloud Costs, Increase Cloud Security, and Improve Operational Efficiencies with Upland Cimpl Cloud


Upland Software, Inc. (Nasdaq: UPLD) announces the release of Cimpl Cloud, a new capability from its Cimpl product built to help customers reduce cost in their complex cloud environments, minimize

Perion Network Announces Upsize and Pricing of Approximately $156.5 Million Follow-on Offering of Ordinary Shares: https://mms.businesswire.com/media/20191107005494/en/755179/5/Perion_triangles_%28002%29.jpg
Perion Network Announces Upsize and Pricing of Approximately $156.5 Million Follow-on Offering of Ordinary Shares


Perion Network Ltd. (NASDAQ: PERI), a global advertising technology company that delivers holistic solutions across the three main pillars of digital advertising – ad search, social media and

Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group plc
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group plc
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group plc
Clovis Oncology Highlights FAP-2286 Preclinical Data Presented at the Targeted Radiopharmaceuticals Summit: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg
Clovis Oncology Highlights FAP-2286 Preclinical Data Presented at the Targeted Radiopharmaceuticals Summit


Clovis Oncology, Inc. (NASDAQ: CLVS) announced today’s presentation by Andrew D. Simmons, Ph.D., Clovis’ Senior Vice President, Translational Medicine, at the 3rd Targeted Radiopharmaceuticals

DGAP-News: Außerordentliche Hauptversammlung der Aareal Bank AG beschließt Abwahl von Mitgliedern des Aufsichtsrats: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23689/375px-Aareal_Bank_Logo.svg.png
DGAP-News: Außerordentliche Hauptversammlung der Aareal Bank AG beschließt Abwahl von Mitgliedern des Aufsichtsrats
DGAP-News: Außerordentliche Hauptversammlung der Aareal Bank AG beschließt Abwahl von Mitgliedern des Aufsichtsrats
DGAP-News: Extraordinary General Meeting of Aareal Bank AG resolves on the removal of Supervisory Board members: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23689/375px-Aareal_Bank_Logo.svg.png
DGAP-News: Extraordinary General Meeting of Aareal Bank AG resolves on the removal of Supervisory Board members
DGAP-News: Extraordinary General Meeting of Aareal Bank AG resolves on the removal of Supervisory Board members
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN): https://mms.businesswire.com/media/20191107005278/en/707846/5/Aurinia-logo-web-700px.jpg
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)


Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced

DGAP-News: Biotest AG: Biotest Aufsichtsrat beruft neues Vorstandsmitglied: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-News: Biotest AG: Biotest Aufsichtsrat beruft neues Vorstandsmitglied
DGAP-News: Biotest AG: Biotest Aufsichtsrat beruft neues Vorstandsmitglied
DGAP-News: Biotest AG: Biotest Supervisory Board appoints new Management Board member: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-News: Biotest AG: Biotest Supervisory Board appoints new Management Board member
DGAP-News: Biotest AG: Biotest Supervisory Board appoints new Management Board member
ADVA boosts PNT resilience with new software release
ADVA boosts PNT resilience with new software release


ADVA (FSE: ADV) today announced the latest software release of its core and edge timing technology, bringing new levels of PNT security and resilience to synchronization networks. The upgraded

ADVA verbessert die Zuverlässigkeit von PNT mit neuem Software-Release
ADVA verbessert die Zuverlässigkeit von PNT mit neuem Software-Release


ADVA (FWB: ADV) kündigte heute das neueste Software-Release seiner Timing-Lösung für das Kern- und Aggregationsnetz an. Damit wird ein neues Maß an Ausfallsicherheit und Widerstandsfähigkeit für

RM plc: Full Year Trading Update:
RM plc: Full Year Trading Update
RM plc: Full Year Trading Update
DGAP-News: Target for 2021 already achieved: Acquisitions totalling c. EUR 1.3 billion - further projects until year-end in preparation - successful year for the team of DIC Asset AGThomas Pfaff Kommunikation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/17644/DIC_Asset_Logo_2014_4C.jpg
DGAP-News: Target for 2021 already achieved: Acquisitions totalling c. EUR 1.3 billion - further projects until year-end in preparation - successful year for the team of DIC Asset AG
DGAP-News: Target for 2021 already achieved: Acquisitions totalling c. EUR 1.3 billion - further projects until year-end in preparation - successful year for the team of DIC Asset AG
DGAP-News: Ziel für 2021 bereits erreicht: Ankäufe für rund 1,3 Mrd. Euro - weitere Projekte bis zum Jahresende in Vorbereitung - erfolgreiches Jahr für das Team der DIC Asset AGThomas Pfaff Kommunikation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/17644/DIC_Asset_Logo_2014_4C.jpg
DGAP-News: Ziel für 2021 bereits erreicht: Ankäufe für rund 1,3 Mrd. Euro - weitere Projekte bis zum Jahresende in Vorbereitung - erfolgreiches Jahr für das Team der DIC Asset AG
DGAP-News: Ziel für 2021 bereits erreicht: Ankäufe für rund 1,3 Mrd. Euro - weitere Projekte bis zum Jahresende in Vorbereitung - erfolgreiches Jahr für das Team der DIC Asset AG
Perion Network Launches Proposed Follow-on Offering of Ordinary Shares to Fund Continued Growth: https://mms.businesswire.com/media/20191107005494/en/755179/5/Perion_triangles_%28002%29.jpg
Perion Network Launches Proposed Follow-on Offering of Ordinary Shares to Fund Continued Growth


Perion Network Ltd. (NASDAQ: PERI), a global advertising technology company that delivers holistic solutions across the three main pillars of digital advertising – ad search, social media and

General American Investors Company Announces: Actions Taken by the Board of Directors:
General American Investors Company Announces: Actions Taken by the Board of Directors


The Board of Directors of General American Investors Company, Inc., a closed-end investment company whose common and preferred shares are listed on the New York Stock Exchange (NYSE symbols - GAM

Perion Accelerates Its Strong Business Momentum; Raises Full-Year 2021 and 2022 Guidance for Revenue and Adjusted EBITDA: https://mms.businesswire.com/media/20191107005494/en/755179/5/Perion_triangles_%28002%29.jpg
Perion Accelerates Its Strong Business Momentum; Raises Full-Year 2021 and 2022 Guidance for Revenue and Adjusted EBITDA


Perion Network Ltd. (NASDAQ: PERI), a global advertising technology company that delivers a holistic solution across the three main pillars of digital advertising – ad search, social media, and

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital


Regulatory News:



Nanobiotix (Paris:NANO) (NASDAQ:NBTX):



Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website

DGAP-News: Biotest AG: Biotest adjusts guidance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-News: Biotest AG: Biotest adjusts guidance
DGAP-News: Biotest AG: Biotest adjusts guidance
DGAP-News: Biotest AG: Biotest passt Prognose an: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-News: Biotest AG: Biotest passt Prognose an
DGAP-News: Biotest AG: Biotest passt Prognose an
DGAP-Adhoc: Biotest AG: Reduction of guidance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-Adhoc: Biotest AG: Reduction of guidance
DGAP-Adhoc: Biotest AG: Reduction of guidance
DGAP-Adhoc: Biotest AG: Absenkung der Prognose: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-Adhoc: Biotest AG: Absenkung der Prognose
DGAP-Adhoc: Biotest AG: Absenkung der Prognose
Tessco Provides Update to SaaS Platform that Supports Device Monitoring and Management
Tessco Provides Update to SaaS Platform that Supports Device Monitoring and Management


TESSCO Technologies Incorporated (NASDAQ: TESS), a leading value-added distributor to the wireless infrastructure construction industry, provided an update to its recently launched Device Lifecycle

Elys Game Technology Provides Call Coordinates for 2021 Annual Meeting of Shareholders
Elys Game Technology Provides Call Coordinates for 2021 Annual Meeting of Shareholders


Elys Game Technology, Corp. (“Elys” or the “Company”) (Nasdaq:ELYS)(NEO:ELYS)(BER:3UW), an interactive gaming and sports betting technology company, provides an update for its annual meeting of

ISG to Ring Nasdaq Opening Bell: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
ISG to Ring Nasdaq Opening Bell


Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, will ring the opening bell at the Nasdaq MarketSite in New York’s Times Square today to mark